Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine in Severe Falciparum Malaria
NCT00616304Phase 2Suspended
- Sponsor
- Menzies School of Health Research
- Start
- Feb 2008
- Primary completion
- Mar 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in malaria, sponsored by Menzies School of Health Research. Started Feb 2008; status: suspended.
02
Drugs
arginine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00616304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616304.